Sukru H. Emre MD
Professor of Surgery (Transplant) and of Pediatrics; Section Chief, Transplantation Surgery; Director, Yale-New Haven Transplant Center
Departments & OrganizationsYale Medical Group
Cancer Center, Yale: Gastrointestinal Cancer Program
Transplantation Center, Yale-New Haven
Pediatrics: Pediatric Gastroenterology & Hepatology: Joint Interdepartmental Program
Surgery: Transplantation & Immunology (Liver/Kidney/Pancreas)
Dr. Sukru Emre oversees the activities of Yale-New Haven Transplantation Center and its multidisciplinary group of physicians and caregivers, and continues to offer his specialty, adult and pediatric liver transplantation. Dr. Emre is section chief of transplant surgery and immunology in the department of surgery at Yale School of Medicine.
Dr. Emre received his medical degree from the University of Istanbul where he also completed a residency in general surgery. His clinical post-doctoral training includes completion of a hepatobiliary surgery fellowship at the University of Istanbul and a transplant fellowship at the Mount Sinai Medical Center in New York. He also completed two transplantation research fellowships, one at SUNY Health Science Center at Brooklyn and another at the Mount Sinai Medical Center in New York. He holds a foreign board certification in general surgery and is a Fellow of the American College of Surgeons.
Dr. Emre is an expert in adult and pediatric liver transplantations. He has performed more than 1,500 liver transplants, of which the youngest patient was 16 days old and the oldest was 75 years old. His special interests are performing split-liver transplants (dividing a liver between two recipients thus saving two lives) and living donor transplants which involves transplanting a portion of a donor's healthy liver. He is also expert in hepato-biliary surgery including resection for liver cancer, portal hypertension surgery, repair of complex bile duct injuries and Kasai procedure for biliary atresia. Dr. Emre's research interests include acute liver failure, biliary atresia and rare cholestatic diseases in children, and transplanting adult patients with hepatitis B, C and liver cancer.